Recent developments in immunotoxin therapy
- 31 December 1994
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 6 (5) , 707-714
- https://doi.org/10.1016/0952-7915(94)90073-6
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Expression of immunoglobulin heavy chain-ricin a chain fusions in mammalian cellsMolecular Immunology, 1994
- Anti-CD6-blocked ricin: An anti-pan T-cell immunotoxinInternational Journal of Immunopharmacology, 1994
- Efficacy of anti-CD5 F(AB′)2 and FAB′ immunoconjugates in human peripheral blood lymphocyte-reconstituted severe combined immunodeficient miceInternational Journal of Immunopharmacology, 1993
- IMMUNOTOXINS FOR THE TREATMENT OF LEUKAEMIABritish Journal of Haematology, 1993
- In vitro and in vivo properties of an anti-CD5—momordin immunotoxin on normal and neoplastic T lymphocytesCancer Immunology, Immunotherapy, 1993
- Efficacy of an anti-CD5-ricin a chain immunoconjugate in an improved human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mouse modelInternational Journal of Immunopharmacology, 1993
- Immunotoxins: magic bullets or misguided missiles?Immunology Today, 1993
- Phase I/II Study of Murine Monoclonal Antibody-Ricin A Chain (XOMAZYME-Mel) Immunoconjugate plus Cyclosporine A in Patients with Metastatic MelanomaJournal of Immunotherapy, 1993
- Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancerCancer Immunology, Immunotherapy, 1992
- Polyethylene glycol modification of the monoclonal antibody A7 enhances its tumor localizationBiochemical and Biophysical Research Communications, 1990